Literature DB >> 26496662

Myelin-specific T cells induce interleukin-1beta expression in lesion-reactive microglial-like cells in zones of axonal degeneration.

Manuela Grebing1, Helle H Nielsen2, Christina D Fenger1, Katrine T Jensen1, Christian U von Linstow1, Bettina H Clausen1, Martin Söderman1, Kate L Lambertsen1, Mads Thomassen3, Torben A Kruse3, Bente Finsen1.   

Abstract

Infiltration of myelin-specific T cells into the central nervous system induces the expression of proinflammatory cytokines in patients with multiple sclerosis (MS). We have previously shown that myelin-specific T cells are recruited into zones of axonal degeneration, where they stimulate lesion-reactive microglia. To gain mechanistic insight, we used RNA microarray analysis to compare the transcript profile in hippocampi from perforant pathway axonal-lesioned mice with and without adoptively transferred myelin-specific T cells 2 days postlesion, when microglia are clearly lesion reactive. Pathway analysis revealed that, among the 1,447 differently expressed transcripts, the interleukin (IL)-1 pathway including all IL-1 receptor ligands was upregulated in the presence of myelin-specific T cells. Quantitative polymerase chain reaction showed increased mRNA levels of IL-1β, IL-1α, and IL-1 receptor antagonist in the T-cell-infiltrated hippocampi from axonal-lesioned mice. In situ hybridization and immunohistochemistry showed a T-cell-enhanced lesion-specific expression of IL-1β mRNA and protein, respectively, and induction of the apoptosis-associated speck-like protein, ASC, in CD11b(+) cells. Double in situ hybridization showed colocalization of IL-1β mRNA in a subset of CD11b mRNA(+) cells, of which many were part of cellular doublets or clusters, characteristic of proliferating, lesion-reactive microglia. Double-immunofluorescence showed a T-cell-enhanced colocalization of IL-1β to CD11b(+) cells, including lesion-reactive CD11b(+) ramified microglia. These results suggest that myelin-specific T cells stimulate lesion-reactive microglial-like cells to produce IL-1β. These findings are relevant to understand the consequences of T-cell infiltration in white and gray matter lesions in patients with MS.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Wallerian degeneration; cytokines; demyelination; gray matter; multiple sclerosis

Mesh:

Substances:

Year:  2015        PMID: 26496662     DOI: 10.1002/glia.22937

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  10 in total

Review 1.  The IL-1β phenomena in neuroinflammatory diseases.

Authors:  Andrew S Mendiola; Astrid E Cardona
Journal:  J Neural Transm (Vienna)       Date:  2017-05-22       Impact factor: 3.575

Review 2.  The role of antiviral CD8+ T cells in cognitive impairment.

Authors:  Katie L Reagin; Kristen E Funk
Journal:  Curr Opin Neurobiol       Date:  2022-07-08       Impact factor: 7.070

Review 3.  When encephalitogenic T cells collaborate with microglia in multiple sclerosis.

Authors:  Yifei Dong; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2019-09-16       Impact factor: 42.937

Review 4.  Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk.

Authors:  Gaigai Li; Prativa Sherchan; Zhouping Tang; Jiping Tang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

5.  Neuroinflammation: Microglia and T Cells Get Ready to Tango.

Authors:  Sjoerd T T Schetters; Diego Gomez-Nicola; Juan J Garcia-Vallejo; Yvette Van Kooyk
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

6.  Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer's disease.

Authors:  Athanasios Metaxas; Marco Anzalone; Ramanan Vaitheeswaran; Sussanne Petersen; Anne M Landau; Bente Finsen
Journal:  Alzheimers Res Ther       Date:  2019-05-01       Impact factor: 6.982

7.  Microglia Express Insulin-Like Growth Factor-1 in the Hippocampus of Aged APPswe/PS1ΔE9 Transgenic Mice.

Authors:  Christa Løth Myhre; Camilla Thygesen; Birgitte Villadsen; Jeanette Vollerup; Laura Ilkjær; Katrine Tækker Krohn; Manuela Grebing; Shuainan Zhao; Asif Manzoor Khan; Lasse Dissing-Olesen; Morten Skovgaard Jensen; Alicia A Babcock; Bente Finsen
Journal:  Front Cell Neurosci       Date:  2019-07-30       Impact factor: 5.505

8.  Natalizumab treatment reduces microglial activation in the white matter of the MS brain.

Authors:  Marcus Sucksdorff; Jouni Tuisku; Markus Matilainen; Anna Vuorimaa; Sarah Smith; Joonas Keitilä; Johanna Rokka; Riitta Parkkola; Marjo Nylund; Juha Rinne; Eero Rissanen; Laura Airas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-06-07

Review 9.  Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.

Authors:  Jatin Machhi; Bhavesh D Kevadiya; Ijaz Khan Muhammad; Jonathan Herskovitz; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  Mol Neurodegener       Date:  2020-06-05       Impact factor: 14.195

10.  Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.

Authors:  Saskia Maria Burm; Laura Anna Norma Peferoen; Ella Alwine Zuiderwijk-Sick; Krista Geraldine Haanstra; Bert Adriaan 't Hart; Paul van der Valk; Sandra Amor; Jan Bauer; Jeffrey John Bajramovic
Journal:  J Neuroinflammation       Date:  2016-06-06       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.